The tragic case of Ella Nanda Sari Hasibuan has drawn significant attention across Indonesia, highlighting critical issues around cosmetic procedure safety, medical oversight, and the vulnerable position of medical patients. Ella Nanda Sari Hasibuan, a 30yearold woman from Medan, unfortunately passed away after undergoing a liposuction procedure at a clinic in Depok in July 2024. Her story has raised questions about clinic regulatory compliance, patient consent, and the accountability of medical practitioners who offer highrisk treatments. The public response reflects deep concern over cosmetic medical practices and underscores the importance of clear regulations, informed patient decisions, and robust oversight by health authorities.
Who Was Ella Nanda Sari Hasibuan
Ella Nanda Sari Hasibuan was reported to be a social media personality or selebgram based in Medan, North Sumatra. According to media sources, she travelled from Medan to Jakarta’s environs to attend a scheduled cosmetic liposuction at a clinic in Depok. Her case became widely publicised because of the circumstances surrounding her death and the alleged negligence tied to the procedure.
Her background prior to the procedure was described in media reports as someone seeking aesthetic improvement, which is a growing trend in Indonesia. While details about her personal and professional life remain limited in public records, Ella’s case serves as a reminder of how ordinary people engaging with cosmetic treatments can face profound risks.
The Events Leading to the Procedure
On 22 July 2024, Ella travelled from Medan’s Kualanamu airport to Jakarta, then was driven to a clinic in Depok for a liposuction treatment scheduled for around 1300 WIB. The clinic received her in the late morning, and shortly thereafter, complications occurred. There was reporting that Ella fainted during the procedure and was then rushed by a driver to RS Bunda Margonda in Depok. By the time she arrived, the hospital declared her deceased.
Her brother, Okta Hasibuan, recounted how the news came unexpectedly and how the clinic allegedly was not forthcoming with full details, including medical records. The incident prompted investigative responses from police and health authorities in Depok.
Investigation and Legal Proceedings
Following Ella’s death, law enforcement and health officials initiated an investigation into the clinic and the medical practitioners involved. Authorities sought to determine whether the doctor performing the liposuction was properly licensed, whether the clinic adhered to regulated procedures, and whether negligence or malpractice played a role.
In February 2025, a clinic doctor named Wid Setiawan Jaya (WSJ) Apronso Lambohan Hutagalung was convicted by the Depok District Court (Pengadilan Negeri Depok) for negligence leading to death, under Indonesia’s Health Law (UU No.17 2023). The verdict imposed a prison sentence of one year and four months, which was slightly lower than the prosecution’s original request of one year and eight months.
Regulatory Implications and Health Oversight
The case of Ella has stirred public discourse on regulatory oversight of cosmetic and aesthetic medical practices in Indonesia. Clinics offering liposuction, fillers, and other cosmetic procedures are subject to health authority regulations, yet this case revealed potential gaps in enforcement, transparency and patient protection.
- Questions arose about the qualifications and credentials of the practitioner performing the procedure.
- Whether the clinic had appropriate facilities and emergency protocols for highrisk treatments.
- Details of informed consent whether Ella was fully advised of risks associated with liposuction.
- The role of the provincial health department and its ability to monitor and sanction clinics offering intensive procedures.
Health officials in Depok and adjacent administrations pledged to review licensing, inspection regimes, and the transparency standards of clinics performing invasive cosmetic treatments.
Public Reaction and Community Impact
The public and social media reaction to Ella’s death has been significant. Many expressed sympathy for the family and urged stronger safeguards for patients undergoing aesthetic treatments. The story resonated especially with younger demographics who use social media and see aesthetic procedures as part of lifestyle enhancement.
Her case also sparked conversations around mental health, body image and the pressures to undergo cosmetic treatments in modern society. The fact that Ella travelled interstate for her procedure highlighted how the search for clinics with specific services may expose patients to greater risks, particularly if followup care is not fully coordinated.
Support for the Family and Advocacy
Ella’s family, led by her brother Okta, reportedly intended to pursue legal followup and called for greater accountability. The family’s motives extended beyond compensation they sought clarity on why the procedure led to fatality and how to prevent similar tragedies in the future.
Nongovernmental organizations, patient rights advocates, and medical ethics groups used this incident to push for stronger regulation, especially for clinics located outside major cities, and for more transparent patientclinician communication. The event became a cautionary case study for anyone considering highrisk cosmetic surgery.
Lessons Learned and Looking Forward
From Ella’s story, several key lessons emerge for both patients and the medical community. First, the importance of choosing clinics with verified credentials, clear risk disclosures and emergency protocols cannot be overstated. Patients should ask detailed questions about practitioner experience, equipment, accreditation and postoperative care.
Second, regulatory bodies must ensure that aesthetic clinics, especially those offering invasive procedures, meet rigorous safety standards. This includes verifying practitioner licensure, ensuring equipment is maintained, confirming the availability of anesthesiology and emergency medical teams, and requiring transparent documentation of informed consent.
Third, public awareness campaigns about the risks of cosmetic procedures can help reduce harm. Many individuals underestimate potential complications, especially for treatments advertised as routine or minimally invasive. Ella’s case underlines that even seemingly routine liposuction carries genuine risk.
Future Considerations
- Strengthening crossclinic oversight to standardise safety protocols across regions.
- Mandating mandatory accreditation or certification for clinics performing liposuction and major aesthetic surgery.
- Improving patient education campaigns on the risks and realistic outcomes of cosmetic treatments.
- Encouraging postoperative followup and tracking of patient outcomes to build data on clinic performance.
While no new official update on Ella’s case has been fully publicised beyond the court verdict, her story continues to serve as an important reference point for medical safety in Indonesia’s growing cosmetic treatment market.
The tragic death of Ella Nanda Sari Hasibuan after a liposuction procedure at a clinic in Depok stands as a stark reminder of the risks inherent in modern cosmetic treatments. What began as a personal journey to improve appearance ended in a fatal outcome, prompting legal action, regulatory scrutiny and widespread public reflection. Her case highlights the need for stronger oversight of aesthetic clinics, more transparent patient informed consent, and better awareness of the potential dangers of invasive cosmetic procedures. In the end, the legacy of Ella’s story may lie in improving safety standards and ensuring that no other patient faces the same fate without accountability and support.